115 years of pharmaceutical manufacturing experience
Since the very beginning, Richter has always made the outstanding quality of its products a primary concern, and has been committed to having its drug safety system comply with the highest possible official requirements. In order to achieve efficient operation of supply, the Company is constantly adapting to the current environment by regularly fine-tuning and improving the capacity of its production units, and installing the latest automation technology to support that. Richter focuses on developing and manufacturing central nervous system, cardiovascular and gastroenterological products, muscle relaxants and gynaecological products.
With more than 1,000 people in research and development, Gedeon Richter Plc has become the most important pharmaceutical R&D center in Central and Eastern Europe. Its outstanding innovative activities have been recognized on numerous occasions.
The Company’s pharmaceutical manufacturing segment is showing stable growth every year. The production volume of steroids, their other products and active ingredients is also increasing from year to year. The Richter Group also began manufacturing new products in all of its production sites in 2012.
The regular quality inspections carried out by Hungarian and international authorities as well as business partners confirm that Richter’s manufacturing activities are in good order and that their processes comply with technological standards. Their successfully performed audits encompass the entire manufacturing process and Richter is happy to report positive outcomes.